25 May 2013
Keywords: pharmasset, receive, 5m, roche, under, hcv, drug
Article | 23 July 2007
New Jersey, USA-based clinical-stage pharmaceutical company Pharmasset says that Swiss drug major Roche has initiated long-term toxicology
studies of R7128, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 July 2007
24 May 2013
© 2013 thepharmaletter.com